The IJTLD (ISSN:1815-7920) provides a free-to-publish journal for authors (mainly in LMICs), who lack open access funding and conduct research on respiratory health.
The Journal primarily focuses on infectious diseases, including TB and non-tuberculous mycobacterial (NTM) infections, alongside the role of risk factors and comorbidities, with the aim of improving clinical care, policy and practise.
Individuals and Institutes can subscribe to the IJTLD online, simply e-mail us at subscription@theunion.org
Information for Authors
Abstract and indexing services include: Medline, PubMed, Scopus, EMBASE, Web of Science, SciSearch®, Medical Documentation Service®, ISI Alerting Services, Current Contents®/Clinical Medicine, the Science Citation Index®, the SIIC databases, CLOCKSS and LOCKSS.
Other Information
- Frequency: monthly
- Permission requests: contact IJTLD Editorial Office.
There are no fees for articles that meet our recommended page lengths, but there are fees for additional pages or supplementary data - see Journal Publication Charges
Funding agencies have recently mandated that authors must publish exclusively in fully-OA journals.
We are committed to maintaining the IJTLD for authors in LMICs who lack OA funding, while also launching a new title, IJTLD OPEN, which covers a broader range of topics with additional article types.
To ensure we apply the same quality standards for open access publishing, both journals have the same Editorial Board with an identical peer review process and acceptance criteria. Before submitting, please check whether your article is better suited to the IJTLD or IJTLD Open.
The latest peer-reviewed articles on TB and HIV; respiratory diseases such as asthma and COPD; and the hazards of tobacco and air pollution. Recent coverage has expended to include COVID-19 and the interplay between TB-COVID-19 and other co-morbidities.
Individuals and institutes can subscribe to the IJTLD online – see our Subscription information or e-mail us at subscription@theunion.org for details.
Advertising or sponsoring content is an effective means of reaching clinicians, researchers, health workers, decision makers and students.
Sponsors can support the creation of a Collection or a Supplement on a relevant topic of interest, either in print or a digital collection of articles, for elevated visibility of your products and services.
Other opportunities include being involved in the creation of informative Posters, Infographics, or scientific Animations to clarify relevant biological processes.
IJTLD Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and publishing them in full on our website, prior to their publication in the Journal. Read fast-track articles:
Progress on indoor air quality regulation in India
The power of the pen - Correspondence in a forthcoming issue of the IJTLD highlights how a Letter to the Editor helped to progress legislation on indoor air quality in India. The preprint is free to read.
WHO drug-resistant TB guidelines 2022: what is new?
An Editorial in a forthcoming issue of the IJTLD examines the WHO's recent rapid communication on key changes to the treatment of drug-resistant TB. The preprint is free to read.
The Asthma Drug Facility and the future management of asthma
An Editorial in the next issue of the IJTLD examines lessons learned from the Asthma Drug Facility and how this informs future plans for asthma management. The preprint is free to read.
Other versions of the journal
The IJTLD has been published in several languages, and publishes the Union World Conference abstract book each year.
Contact
For all IJTLD enquiries, please contact the IJTLD Editorial Office.